Review



recombinant mouse rae 1 epsilon fc chimera protein  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    R&D Systems recombinant mouse rae 1 epsilon fc chimera protein
    Recombinant Mouse Rae 1 Epsilon Fc Chimera Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse rae 1 epsilon fc chimera protein/product/R&D Systems
    Average 91 stars, based on 3 article reviews
    recombinant mouse rae 1 epsilon fc chimera protein - by Bioz Stars, 2026-03
    91/100 stars

    Images



    Similar Products

    91
    R&D Systems recombinant mouse rae 1 epsilon fc chimera protein
    Recombinant Mouse Rae 1 Epsilon Fc Chimera Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse rae 1 epsilon fc chimera protein/product/R&D Systems
    Average 91 stars, based on 1 article reviews
    recombinant mouse rae 1 epsilon fc chimera protein - by Bioz Stars, 2026-03
    91/100 stars
      Buy from Supplier

    90
    R&D Systems recombinant mouse rae1 fc chimeric protein
    (A) Diagram showing construction of treatment (mNKG2D-2C11) and control (TZ47-2C11) bsTCEs. (B-D) MC38 (1x106) cells were injected s.c. into WT B6 mice. Treatment was initiated when tumors reached approximately 40mm2. (B) Mice received a total of four 10μg i.v injections of bsTCE every other day. (Left) Health scoring was blinded and evaluated 3h and 24h after each treatment. (Right) Weight, normalized to day 0, at the indicated time points. Data pooled from 7 experiments (n=30) (C) Mice received a total of four i.v. injections of either 2, 5 or 10μg bsTCE every other day. Health scoring was blinded and evaluated every hour for the first 8h and then 24h after each treatment. Data pooled from 2 experiments (n=8). (D) Tumor or non-tumor bearing WT B6 mice received a total of four 10μg i.v injections of bsTCE every other day. Health scoring was blinded and evaluated 3h and 24h after each treatment. Data are pooled from two experiment (n=8). (E) Representative images of <t>Rae1</t> positive staining in the liver of B6 mice or contiguous tissue sections blocked with <t>recombinant</t> Rae1. Slides counterstained with methylene blue. Health scores in B and D are shown +/− SD, weight and C are shown +/− SEM. Statistical significance determined by repeated measures two-way ANOVA with Bonferroni’s multiple comparisons test (B, C) or with Tukey multiple comparisons test (D). * p<0.05, *** p<0.001, NS = not statistically significant.
    Recombinant Mouse Rae1 Fc Chimeric Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse rae1 fc chimeric protein/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    recombinant mouse rae1 fc chimeric protein - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    91
    R&D Systems recombinant mouse rae 1ε protein
    (A) Diagram showing construction of treatment (mNKG2D-2C11) and control (TZ47-2C11) bsTCEs. (B-D) MC38 (1x106) cells were injected s.c. into WT B6 mice. Treatment was initiated when tumors reached approximately 40mm2. (B) Mice received a total of four 10μg i.v injections of bsTCE every other day. (Left) Health scoring was blinded and evaluated 3h and 24h after each treatment. (Right) Weight, normalized to day 0, at the indicated time points. Data pooled from 7 experiments (n=30) (C) Mice received a total of four i.v. injections of either 2, 5 or 10μg bsTCE every other day. Health scoring was blinded and evaluated every hour for the first 8h and then 24h after each treatment. Data pooled from 2 experiments (n=8). (D) Tumor or non-tumor bearing WT B6 mice received a total of four 10μg i.v injections of bsTCE every other day. Health scoring was blinded and evaluated 3h and 24h after each treatment. Data are pooled from two experiment (n=8). (E) Representative images of <t>Rae1</t> positive staining in the liver of B6 mice or contiguous tissue sections blocked with <t>recombinant</t> Rae1. Slides counterstained with methylene blue. Health scores in B and D are shown +/− SD, weight and C are shown +/− SEM. Statistical significance determined by repeated measures two-way ANOVA with Bonferroni’s multiple comparisons test (B, C) or with Tukey multiple comparisons test (D). * p<0.05, *** p<0.001, NS = not statistically significant.
    Recombinant Mouse Rae 1ε Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse rae 1ε protein/product/R&D Systems
    Average 91 stars, based on 1 article reviews
    recombinant mouse rae 1ε protein - by Bioz Stars, 2026-03
    91/100 stars
      Buy from Supplier

    90
    R&D Systems recombinant mouse rae
    Generation and identification of CD86-RAE transgenic mice. The CD86-RAE-1ε transgene encompassing the CD86 promoter, the retinoic acid early transcript-1ε (RAE-1ε) coding sequence, and the bovine growth hormone polyadenylation signal (2·6-kb) (a). Founder mice identified by PCR were further screened by Western blotting. Top, RAE-1ε expression was detected in liver tissues F0-1, -12, -17, -48, -40 mice. Bottom, α-tubulin blot (b). RAE-1ε expression on spleen lymphocytes, as identified by flow cytometry. Grey area: isotype control; dotted line: control mice; solid line: CD86-RAEε mice (c). Immunofluorescence histology of the thymus, intestine, liver, lung and kidney stained with anti-I-A/I-E antibody (green) and <t>anti-RAE-1</t> antibody (red) and counterstained with DAPI. Similar patterns were obtained for the mice of lines 48, 1 and 17. The photographs shown are from a line 48 mouse, and were taken at a magnification of × 200 (d). Changes in RAE-1ε expression on myeloid cells and lymphocytes in response to overnight stimulation with poly (I:C) ex vivo (50 ng/ml) (e) and in vivo (100 μg) (f). Grey area: before stimulation; red line: after stimulation. The figures in black and red show the results before and after stimulation, respectively.
    Recombinant Mouse Rae, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse rae/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    recombinant mouse rae - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Diagram showing construction of treatment (mNKG2D-2C11) and control (TZ47-2C11) bsTCEs. (B-D) MC38 (1x106) cells were injected s.c. into WT B6 mice. Treatment was initiated when tumors reached approximately 40mm2. (B) Mice received a total of four 10μg i.v injections of bsTCE every other day. (Left) Health scoring was blinded and evaluated 3h and 24h after each treatment. (Right) Weight, normalized to day 0, at the indicated time points. Data pooled from 7 experiments (n=30) (C) Mice received a total of four i.v. injections of either 2, 5 or 10μg bsTCE every other day. Health scoring was blinded and evaluated every hour for the first 8h and then 24h after each treatment. Data pooled from 2 experiments (n=8). (D) Tumor or non-tumor bearing WT B6 mice received a total of four 10μg i.v injections of bsTCE every other day. Health scoring was blinded and evaluated 3h and 24h after each treatment. Data are pooled from two experiment (n=8). (E) Representative images of Rae1 positive staining in the liver of B6 mice or contiguous tissue sections blocked with recombinant Rae1. Slides counterstained with methylene blue. Health scores in B and D are shown +/− SD, weight and C are shown +/− SEM. Statistical significance determined by repeated measures two-way ANOVA with Bonferroni’s multiple comparisons test (B, C) or with Tukey multiple comparisons test (D). * p<0.05, *** p<0.001, NS = not statistically significant.

    Journal: Journal of immunology (Baltimore, Md. : 1950)

    Article Title: Toxicity induced by a bispecific T cell redirecting protein is mediated by both T cells and myeloid cells in immunocompetent mice 2

    doi: 10.4049/jimmunol.1901401

    Figure Lengend Snippet: (A) Diagram showing construction of treatment (mNKG2D-2C11) and control (TZ47-2C11) bsTCEs. (B-D) MC38 (1x106) cells were injected s.c. into WT B6 mice. Treatment was initiated when tumors reached approximately 40mm2. (B) Mice received a total of four 10μg i.v injections of bsTCE every other day. (Left) Health scoring was blinded and evaluated 3h and 24h after each treatment. (Right) Weight, normalized to day 0, at the indicated time points. Data pooled from 7 experiments (n=30) (C) Mice received a total of four i.v. injections of either 2, 5 or 10μg bsTCE every other day. Health scoring was blinded and evaluated every hour for the first 8h and then 24h after each treatment. Data pooled from 2 experiments (n=8). (D) Tumor or non-tumor bearing WT B6 mice received a total of four 10μg i.v injections of bsTCE every other day. Health scoring was blinded and evaluated 3h and 24h after each treatment. Data are pooled from two experiment (n=8). (E) Representative images of Rae1 positive staining in the liver of B6 mice or contiguous tissue sections blocked with recombinant Rae1. Slides counterstained with methylene blue. Health scores in B and D are shown +/− SD, weight and C are shown +/− SEM. Statistical significance determined by repeated measures two-way ANOVA with Bonferroni’s multiple comparisons test (B, C) or with Tukey multiple comparisons test (D). * p<0.05, *** p<0.001, NS = not statistically significant.

    Article Snippet: Contiguous sections from each sample were incubated with primary antibodies pre-incubated for 4 hours with recombinant mouse Rae1 Fc chimeric protein (R&D Systems, 1998-RA) at a 1:10 molar ratio as specificity controls.

    Techniques: Injection, Staining, Recombinant

    Generation and identification of CD86-RAE transgenic mice. The CD86-RAE-1ε transgene encompassing the CD86 promoter, the retinoic acid early transcript-1ε (RAE-1ε) coding sequence, and the bovine growth hormone polyadenylation signal (2·6-kb) (a). Founder mice identified by PCR were further screened by Western blotting. Top, RAE-1ε expression was detected in liver tissues F0-1, -12, -17, -48, -40 mice. Bottom, α-tubulin blot (b). RAE-1ε expression on spleen lymphocytes, as identified by flow cytometry. Grey area: isotype control; dotted line: control mice; solid line: CD86-RAEε mice (c). Immunofluorescence histology of the thymus, intestine, liver, lung and kidney stained with anti-I-A/I-E antibody (green) and anti-RAE-1 antibody (red) and counterstained with DAPI. Similar patterns were obtained for the mice of lines 48, 1 and 17. The photographs shown are from a line 48 mouse, and were taken at a magnification of × 200 (d). Changes in RAE-1ε expression on myeloid cells and lymphocytes in response to overnight stimulation with poly (I:C) ex vivo (50 ng/ml) (e) and in vivo (100 μg) (f). Grey area: before stimulation; red line: after stimulation. The figures in black and red show the results before and after stimulation, respectively.

    Journal: Immunology

    Article Title: CD4 + NKG2D + T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1 ε transgenic mice

    doi: 10.1111/imm.12203

    Figure Lengend Snippet: Generation and identification of CD86-RAE transgenic mice. The CD86-RAE-1ε transgene encompassing the CD86 promoter, the retinoic acid early transcript-1ε (RAE-1ε) coding sequence, and the bovine growth hormone polyadenylation signal (2·6-kb) (a). Founder mice identified by PCR were further screened by Western blotting. Top, RAE-1ε expression was detected in liver tissues F0-1, -12, -17, -48, -40 mice. Bottom, α-tubulin blot (b). RAE-1ε expression on spleen lymphocytes, as identified by flow cytometry. Grey area: isotype control; dotted line: control mice; solid line: CD86-RAEε mice (c). Immunofluorescence histology of the thymus, intestine, liver, lung and kidney stained with anti-I-A/I-E antibody (green) and anti-RAE-1 antibody (red) and counterstained with DAPI. Similar patterns were obtained for the mice of lines 48, 1 and 17. The photographs shown are from a line 48 mouse, and were taken at a magnification of × 200 (d). Changes in RAE-1ε expression on myeloid cells and lymphocytes in response to overnight stimulation with poly (I:C) ex vivo (50 ng/ml) (e) and in vivo (100 μg) (f). Grey area: before stimulation; red line: after stimulation. The figures in black and red show the results before and after stimulation, respectively.

    Article Snippet: In brief, we coated plastic wells with recombinant mouse RAE-1 ε (2 μg; R&D Systems) by incubation at 4° overnight.

    Techniques: Transgenic Assay, Sequencing, Western Blot, Expressing, Flow Cytometry, Immunofluorescence, Staining, Ex Vivo, In Vivo

    Weak NKG2D-dependent function of natural killer (NK) cells in CD86-RAE-1ε mice. NKG2D expression on freshly isolated NK cells, gated on CD3− NK1.1+ cells (a). Transcript levels for NKG2D-L, NKG2D-S, DAP10, and DAP12 in NK cells from wild-type and transgenic mice (b). Killing activities were assessed by both CD107a staining and the lactate dehydrogenase release assay (c). After the incubation of NK cells with Ba/F3-RAE or Ba/F3 cells, CD107a expression on NK cells was assessed by flow cytometry (d). Splenocytes from transgenic mice or wild-type mice were stained with CFSE and PKH-26, respectively, mixed in equal proportions and injected intravenously into recipient mice. After 12 hr, fluorescence ratios were determined for the cells recovered from spleens, by flow cytometry (e). Interferon-γ (IFN-γ) production by NK cells from transgenic mice and wild-type mice stimulated with PMA/ionomycin, Ba/F3 or Ba/F3-RAE cells. Results are expressed as means ± SD. Asterisks indicate P < 0·05 (f).

    Journal: Immunology

    Article Title: CD4 + NKG2D + T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1 ε transgenic mice

    doi: 10.1111/imm.12203

    Figure Lengend Snippet: Weak NKG2D-dependent function of natural killer (NK) cells in CD86-RAE-1ε mice. NKG2D expression on freshly isolated NK cells, gated on CD3− NK1.1+ cells (a). Transcript levels for NKG2D-L, NKG2D-S, DAP10, and DAP12 in NK cells from wild-type and transgenic mice (b). Killing activities were assessed by both CD107a staining and the lactate dehydrogenase release assay (c). After the incubation of NK cells with Ba/F3-RAE or Ba/F3 cells, CD107a expression on NK cells was assessed by flow cytometry (d). Splenocytes from transgenic mice or wild-type mice were stained with CFSE and PKH-26, respectively, mixed in equal proportions and injected intravenously into recipient mice. After 12 hr, fluorescence ratios were determined for the cells recovered from spleens, by flow cytometry (e). Interferon-γ (IFN-γ) production by NK cells from transgenic mice and wild-type mice stimulated with PMA/ionomycin, Ba/F3 or Ba/F3-RAE cells. Results are expressed as means ± SD. Asterisks indicate P < 0·05 (f).

    Article Snippet: In brief, we coated plastic wells with recombinant mouse RAE-1 ε (2 μg; R&D Systems) by incubation at 4° overnight.

    Techniques: Expressing, Isolation, Transgenic Assay, Staining, Release Assay, Incubation, Flow Cytometry, Injection, Fluorescence

    The adoptive transfer of normal natural killer (NK) cells into CD86-RAE-1ε mice decreased NKG2D expression. Splenocytes from wild-type mice were stained with CFSE and intravenously injected into transgenic mice or wild-type mice. Fluorescent cells were recovered after 12 hr. Frequencies of CD3− NK1.1+ NKG2D+ cells in donor mice were analysed before and after injection, and the frequencies of spleen CD3− NK1.1+ NKG2D+ cells in recipient mice were also determined (a). B16BL6-RAE (b) or B16BL6 cells (c) (2 × 106) were injected subcutaneously into the back of the animal (n = 6). Tumour area was determined daily. CD86-RAE-1ε mice and wild-type mice (n = 5) were supplied with drinking water containing 2·5% dextran sodium sulphate (DSS). Body weight was measured daily (d). Expression levels of NKp46, NKG2A, 2B4, Ly49D, Ly49H and KLRG1 on NK cells, identified by gating on CD3− NK1.1+ cells (e). Results are expressed as means ± SD. Asterisks indicate P < 0·05. Each experiment was carried out three times.

    Journal: Immunology

    Article Title: CD4 + NKG2D + T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1 ε transgenic mice

    doi: 10.1111/imm.12203

    Figure Lengend Snippet: The adoptive transfer of normal natural killer (NK) cells into CD86-RAE-1ε mice decreased NKG2D expression. Splenocytes from wild-type mice were stained with CFSE and intravenously injected into transgenic mice or wild-type mice. Fluorescent cells were recovered after 12 hr. Frequencies of CD3− NK1.1+ NKG2D+ cells in donor mice were analysed before and after injection, and the frequencies of spleen CD3− NK1.1+ NKG2D+ cells in recipient mice were also determined (a). B16BL6-RAE (b) or B16BL6 cells (c) (2 × 106) were injected subcutaneously into the back of the animal (n = 6). Tumour area was determined daily. CD86-RAE-1ε mice and wild-type mice (n = 5) were supplied with drinking water containing 2·5% dextran sodium sulphate (DSS). Body weight was measured daily (d). Expression levels of NKp46, NKG2A, 2B4, Ly49D, Ly49H and KLRG1 on NK cells, identified by gating on CD3− NK1.1+ cells (e). Results are expressed as means ± SD. Asterisks indicate P < 0·05. Each experiment was carried out three times.

    Article Snippet: In brief, we coated plastic wells with recombinant mouse RAE-1 ε (2 μg; R&D Systems) by incubation at 4° overnight.

    Techniques: Adoptive Transfer Assay, Expressing, Staining, Injection, Transgenic Assay

    Serum from CD86-RAE-1ε mice did not induce NKG2D down-regulation. The concentration of soluble retinoic acid early transcript (RAE) in the serum was determined with a sandwich ELISA kit (a). Serum levels of antibodies against RAE-1 were determined in an indirect ELISA assay (b). NKG2D expression was assessed on freshly isolated natural killer (NK) cells, and NK cells incubated with serum from a wild-type or transgenic mouse. NK cells were isolated by gating on CD3− NK1.1+ cells (c). The experiment was carried out twice.

    Journal: Immunology

    Article Title: CD4 + NKG2D + T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1 ε transgenic mice

    doi: 10.1111/imm.12203

    Figure Lengend Snippet: Serum from CD86-RAE-1ε mice did not induce NKG2D down-regulation. The concentration of soluble retinoic acid early transcript (RAE) in the serum was determined with a sandwich ELISA kit (a). Serum levels of antibodies against RAE-1 were determined in an indirect ELISA assay (b). NKG2D expression was assessed on freshly isolated natural killer (NK) cells, and NK cells incubated with serum from a wild-type or transgenic mouse. NK cells were isolated by gating on CD3− NK1.1+ cells (c). The experiment was carried out twice.

    Article Snippet: In brief, we coated plastic wells with recombinant mouse RAE-1 ε (2 μg; R&D Systems) by incubation at 4° overnight.

    Techniques: Concentration Assay, Sandwich ELISA, Indirect ELISA, Expressing, Isolation, Incubation, Transgenic Assay

    Sustained retinoic acid early transcript (RAE) expression on dendritic cell-activated natural killer (NK) cells ex vivo. CD107a expression and interferon-γ (IFN-γ) production were assessed for freshly isolated NK cells and after stimulation with dendritic cells from a wild-type mouse or a CD86-RAE-1ε mouse, at a ratio of 1 : 2, for 12 hr or 5 days (a). NKG2D, 2B4 (b), CD69, NKp46, NKG2A (c) expression on NK cells stimulated with dendritic cells at a ratio of 1 : 3 for 12 hr, as measured by flow cytometry, with gating on CD3− NK1.1+ cells.

    Journal: Immunology

    Article Title: CD4 + NKG2D + T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1 ε transgenic mice

    doi: 10.1111/imm.12203

    Figure Lengend Snippet: Sustained retinoic acid early transcript (RAE) expression on dendritic cell-activated natural killer (NK) cells ex vivo. CD107a expression and interferon-γ (IFN-γ) production were assessed for freshly isolated NK cells and after stimulation with dendritic cells from a wild-type mouse or a CD86-RAE-1ε mouse, at a ratio of 1 : 2, for 12 hr or 5 days (a). NKG2D, 2B4 (b), CD69, NKp46, NKG2A (c) expression on NK cells stimulated with dendritic cells at a ratio of 1 : 3 for 12 hr, as measured by flow cytometry, with gating on CD3− NK1.1+ cells.

    Article Snippet: In brief, we coated plastic wells with recombinant mouse RAE-1 ε (2 μg; R&D Systems) by incubation at 4° overnight.

    Techniques: Expressing, Ex Vivo, Isolation, Flow Cytometry

    CD4+ NKG2D+ T cells contributed to the down-regulation of NKG2D on natural killer (NK) cells. Frequencies and absolute numbers of CD4+ NKG2D+ T cells in the spleen were compared between CD86-RAE-1ε mice and wild-type mice (a). Transforming growth factor-β (TGF-β) was detected by flow cytometry, with intracellular staining and gating on CD4+ NKG2D− T cells and CD4+ NKG2D+ T cells (b). NKG2D expression on CD3− NK1.1+ cells was determined following the co-culture of normal NK cells, in a 1 : 1 ratio, with CD4+ NKG2D− T cells, CD4+ NKG2D+ T cells, or CD4+ NKG2D+ T cells in the presence of anti-TGF-β antibody, for 24 hr (c). CD4+ NKG2D+ T cells did not express Foxp3, as shown by flow cytometry (d). Asterisks indicate that P < 0·05. The experiment was carried out three times.

    Journal: Immunology

    Article Title: CD4 + NKG2D + T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1 ε transgenic mice

    doi: 10.1111/imm.12203

    Figure Lengend Snippet: CD4+ NKG2D+ T cells contributed to the down-regulation of NKG2D on natural killer (NK) cells. Frequencies and absolute numbers of CD4+ NKG2D+ T cells in the spleen were compared between CD86-RAE-1ε mice and wild-type mice (a). Transforming growth factor-β (TGF-β) was detected by flow cytometry, with intracellular staining and gating on CD4+ NKG2D− T cells and CD4+ NKG2D+ T cells (b). NKG2D expression on CD3− NK1.1+ cells was determined following the co-culture of normal NK cells, in a 1 : 1 ratio, with CD4+ NKG2D− T cells, CD4+ NKG2D+ T cells, or CD4+ NKG2D+ T cells in the presence of anti-TGF-β antibody, for 24 hr (c). CD4+ NKG2D+ T cells did not express Foxp3, as shown by flow cytometry (d). Asterisks indicate that P < 0·05. The experiment was carried out three times.

    Article Snippet: In brief, we coated plastic wells with recombinant mouse RAE-1 ε (2 μg; R&D Systems) by incubation at 4° overnight.

    Techniques: Flow Cytometry, Staining, Expressing, Co-Culture Assay